用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网最新消息社区报道
关键字  范围   
 
The FDA has recently approved the following devices to be marketed.
2024/10/13 20:33:36 | 浏览:902 | 评论:0

The FDA has recently approved the following devices to be marketed.

Occlutech ASD Occluder and Occlutech Pistol Pusher – P200032

The Occlutech ASD Occluder is a permanent implant intended to treat an atrial septal defect (ASD). The device has two umbrella-shaped flexible discs with a connection in the middle. When the device is carefully positioned in the ASD, the two discs cover both sides of the atrial septum, closing the hole. After a few months, the device will be covered by a thin layer of tissue.

The FDA has recently approved the following devices to be marketed.

TZ Medical Adult and Pediatric Multi-Function Defibrillation Electrodes and Adaptors – P200005

TZ Medical Multi-Function Defibrillation Electrodes and Adaptors monitor the heart’s rhythm and deliver a pacing or electrical shock from a defibrillator(a device that applies an electric charge to the heart to restore a normal heartbeat)to a person with an arrhythmia.

The FDA has recently approved the following devices to be marketed.


Edwards EVOQUE Tricuspid Valve Replacement System – P230013

The Edwards EVOQUE Tricuspid Valve Replacement System mainly includes an artificial tricuspid valve(called the EVOQUE valve)and a delivery catheter. The EVOQUE valve is made of cow tissue attached to a self-expanding metal(nickel-titanium)frame for support. It can be used to replace the tricuspid valve of the heart without open-heart surgery. The tricuspid valve prevents backflow of blood into the right atrium(upper right chamber of the heart)from the right ventricle(lower right chamber of the heart).

The FDA has recently approved the following devices to be marketed.

Spectra WaveWriter, WaveWriter Alpha, WaveWriter Alpha Prime Spinal Cord Stimulation Systems - P030017/S363

Boston Scientific’s WaveWriter Spinal Cord Stimulation(SCS)Systems are implanted(placed into the body)to help reduce pain that is chronic(long-term)and intractable(difficult to manage)in the legs, arms, or trunk. This supplement expands the Indications for Use to include treatment of low back and leg pain that is difficult to manage without prior back surgery.

The FDA has recently approved the following devices to be marketed.

XACT Carotid Stent System – P040038/S043

The XACT Carotid Stent System is intended to be used to reopen narrowed parts of the carotid arteries in the neck that supply blood to the brain. The system consists of a delivery catheter and a self-expanding metal stent made of nitinol.
This approval expands the indications for the XACT Carotid Stent System to be used during a Transcarotid Artery Revascularization(TCAR)procedure, in which a device is placed in the neck instead of in the thigh in combination with the ENROUTE Transcarotid Neuroprotection System(ENROUTE NPS). The ENROUTE NPS temporarily reverses blood flow at the treatment area to redirect pieces that may become loose during the procedure from potentially traveling to the brain.

The FDA has recently approved the following devices to be marketed.

Xstim Spine Fusion Stimulator – P230025

The Xstim Spine Fusion Stimulator is a bone growth stimulator(BGS)device intended be used on the lower back. The device components include a controller for creating signals, a belt clip, a rechargeable lithium-ion battery pack and charging unit, controller cables, hydrogel electrode pads that stick to the skin, optional electrode covers, including some for use only when showering, and a carry case.

The FDA has recently approved the following devices to be marketed.

INTELLANAV STABLEPOINT™ Ablation Catheter & Force Sensing System on the RHYTHMIA HDX™ Mapping System - P150005/S074

The INTELLANAV STABLEPOINT Ablation Catheter uses radiofrequency(RF)energy applied by the catheter tip to destroy heart tissue cells that are causing heart rhythm problems(arrhythmias).

The FDA has recently approved the following devices to be marketed.

 

Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation Systems – P150031/S064

The Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation(DBS)Systems are implantable devices that deliver low-intensity electrical pulses to nerve centers in the brain. This supplement expands the Indications for Use to include an option of two-sided stimulation for people who are diagnosed with essential tremor not adequately controlled by medication and where the tremor creates a significant inability to function.

The FDA has recently approved the following devices to be marketed.

AGENT Paclitaxel-Coated Balloon Catheter – P230035

The AGENT Paclitaxel-Coated Balloon Catheter(Agent DCB)uses a narrow tube with a balloon on the end to reopen arteries that supply blood to the heart and are blocked or narrowed due to coronary artery disease(CAD). The balloon is coated on its outer surface with the drug paclitaxel, which may help prevent the arteries from narrowing again(restenosis).

The FDA has recently approved the following devices to be marketed.

LIAISON Biotrin Parvovirus B19 IgG Plus, LIAISON Biotrin Control Parvovirus B19 IgG Plus – P220034

The LIAISON Biotrin Parvovirus B19 IgG Plus is a laboratory test used to detect human parvovirus IgG antibodies against the parvovirus B19 antigen in the blood.

The FDA has recently approved the following devices to be marketed.

 

TriClip G4 System – P230007

The TriClip G4 System is used to treat tricuspid regurgitation(leaky tricuspid valve)often caused by an enlarged heart or damaged tricuspid valve leaflets, without open-heart surgery.

The FDA has recently approved the following devices to be marketed.

ColoSense – P230001

ColoSense is a laboratory test that measures ribonucleic acid(RNA)and hemoglobin(blood)in human stool that is not visible to the eye(fecal occult blood), which may indicate the presence of colorectal cancer or of advanced adenomas(growths on the lining of the colon or rectum). The ColoSense Collection Kit consists of a container for collection of stool and a separate sampler for collection of stool for hemoglobin testing(only one stool is required to obtain both samples). Both samples are required to obtain a ColoSense result. Additionally, bowel prep or following dietary or medication restrictions to complete the test is not necessary.


相关栏目:『社区报道
特斯拉前华裔工程师被控窃密!窃取Optimus机器人核心技术 2025-07-01 [62]
教育资讯 | 《华盛顿邮报》等:美国学术自由、国家安全与高教信任的三重危机 2025-06-25 [209]
美国华裔美女科学家发明颠覆性中风疗法!血栓清除成功率达90%,或彻底改变游戏规则! 2025-06-21 [1486]
斯坦福李飞飞 | 机器人操作泛化突破!AI 教母再添新成果 2025-06-20 [347]
AI预测失误酿大祸:加州电力公司野火预警系统遭质疑 2025-06-16 [502]
任正非最新发声(信息量有点大) 2025-06-16 [404]
教育资讯 | 美国特朗普政府力推“循证阅读教学法” 2025-06-11 [603]
李飞飞对话 a16z:LLM 是有损压缩,世界模型才是真正重要方向,应用远超机器人 2025-06-11 [556]
政坛地震中心的Big Beautiful Bill(BBB)法案的总结 2025-06-11 [601]
麻省理工学院校长萨莉·科恩布卢斯在2025 届毕业典礼上的演讲全文 2025-06-06 [682]
相关栏目更多文章
最新图文:
:阿尔茨海默病预防与干预核心讯息图解 :引力波天文台或有助搜寻暗物质粒子 :Sail Through the Mist - SoCal Innovation Forum 2019(10/5) 游天龙:《唐人街》是如何炼成的:UCLA社会学教授周敏的学术之路 :“为什么海外华人那么爱国,但是让他回国却不愿意?...“ :学术出版巨头Elsevier 彻查433名审稿人“强迫引用”黑幕 :中国336个国家重点实验室布局 :中澳政府联合出手打击洗钱和逃税漏税 大量中国居民海外账户遭冻结
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2025 ScholarsUpdate.com. All Rights Reserved.